chr12-57091136-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005967.4(NAB2):c.95G>A(p.Arg32Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,515,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005967.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAB2 | NM_005967.4 | c.95G>A | p.Arg32Gln | missense_variant | 2/7 | ENST00000300131.8 | NP_005958.1 | |
NAB2 | NM_001330305.2 | c.95G>A | p.Arg32Gln | missense_variant | 2/6 | NP_001317234.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAB2 | ENST00000300131.8 | c.95G>A | p.Arg32Gln | missense_variant | 2/7 | 1 | NM_005967.4 | ENSP00000300131.3 | ||
NAB2 | ENST00000342556.6 | c.95G>A | p.Arg32Gln | missense_variant | 2/6 | 5 | ENSP00000341491.6 | |||
NAB2 | ENST00000554718.1 | n.209-98G>A | intron_variant | 5 | ||||||
NAB2 | ENST00000555857.1 | n.313-95G>A | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000387 AC: 7AN: 180658Hom.: 0 AF XY: 0.0000315 AC XY: 3AN XY: 95172
GnomAD4 exome AF: 0.0000161 AC: 22AN: 1362856Hom.: 0 Cov.: 31 AF XY: 0.0000180 AC XY: 12AN XY: 666606
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.95G>A (p.R32Q) alteration is located in exon 2 (coding exon 2) of the NAB2 gene. This alteration results from a G to A substitution at nucleotide position 95, causing the arginine (R) at amino acid position 32 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at